C.W. Schmidt

Editor, Harvard Medical School Annual Report on Prostate Diseases

C.W. Schmidt is an award-winning freelance science writer based in Portland, Maine. In addition to writing for 天博体育 Publishing, he has written for Science magazine, the Journal of the National Cancer Institute, Environmental Health Perspectives, Nature Biotechnology, and The Washington Post.

Posts by C.W. Schmidt

$Hormonal therapies for advanced prostate cancer linked to a higher risk of falls and fractures featured image$

C.W. Schmidt

Hormonal therapies for advanced prostate cancer linked to a higher risk of falls and fractures

C.W. Schmidt

New high-resolution imaging scans approved for use in prostate cancer

C.W. Schmidt

The sequence of hormonal therapy and radiation affects outcomes in men treated for prostate cancer

C.W. Schmidt

New online model identifies which men can have fewer biopsies on active surveillance

C.W. Schmidt

Hormonal treatments for prostate cancer may prevent or limit COVID-19 symptoms

C.W. Schmidt

Hormonal treatments for prostate cancer are often given late

C.W. Schmidt

A new hormonal therapy for prostate cancer is under expedited FDA review

C.W. Schmidt

New drugs approved for advanced BRCA-positive prostate cancer

C.W. Schmidt

Combining different biopsies limits uncertainty in prostate cancer diagnosis

C.W. Schmidt

New radiation therapies keep advanced prostate cancer in check

C.W. Schmidt

New study compares long-term side effects from different prostate cancer treatments

C.W. Schmidt

African American and white men who receive comparable treatments for prostate cancer have similar survival

C.W. Schmidt

Researchers urge prostate cancer screening for men with BRCA gene defects

C.W. Schmidt

Most men can hold off on radiation after prostate cancer surgery

C.W. Schmidt

Darolutamide approved for nonmetastatic castration-resistant prostate cancer

Men's Health

Common hormonal treatments linked to abnormal heart rhythms and sudden death in men being treated for prostate cancer

C.W. Schmidt

Popular drugs used for treating enlarged prostates associated with high-grade prostate cancer

C.W. Schmidt

From Brexit to TRexit: Transperineal biopsies pose a challenge to the traditional transrectal biopsy method

C.W. Schmidt

Can a man with abnormal PSA and a negative diagnostic MRI avoid a prostate biopsy? It鈥檚 debatable

C.W. Schmidt

Highly accurate test reveals recurring prostate cancer

Men's Health

African American men respond better to treatments for advanced prostate cancer in clinical trials

C.W. Schmidt

Diet and exercise limit heart disease risk in men undergoing hormonal treatments for advanced prostate cancer

C.W. Schmidt

Hormonal therapy for aggressive prostate cancer: How long is enough?

C.W. Schmidt

Long-term statin use protects against prostate cancer death

Result 49 - 72 of 130